River Global Investors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$1.34M Sell
12,706
-8,378
-40% -$899K 0.26% 65
2024
Q3
$2.28M Buy
21,084
+5,030
+31% +$549K 0.49% 54
2024
Q2
$1.74M Sell
16,054
-239
-1% -$28.2K 0.48% 61
2024
Q1
$2.15M Sell
16,293
-186
-1% -$23.2K 0.54% 57
2023
Q4
$2.01M Buy
16,479
+2,012
+14% +$225K 0.38% 84
2023
Q3
$1.62M Sell
14,467
-2,073
-13% -$263K 0.38% 78
2023
Q2
$2.41M Sell
16,540
-1,230
-7% -$167K 0.48% 61
2023
Q1
$2.29M Sell
17,770
-1,080
-6% -$136K 0.47% 65
2022
Q4
$2.4M Buy
18,850
+1,685
+10% +$196K 0.52% 64
2022
Q3
$1.8M Buy
17,165
+1,270
+8% +$139K 0.34% 93
2022
Q2
$1.67M Buy
15,895
+4,045
+34% +$480K 0.3% 102
2022
Q1
$1.51M Buy
+11,850
New +$1.43M 0.2% 127
2020
Q4
Sell
-4,017
Closed -$531K 145
2020
Q3
$531K Sell
4,017
-4,429
-52% -$579K 0.04% 135
2020
Q2
$979K Buy
8,446
+4,316
+105% +$497K 0.07% 133
2020
Q1
$406K Buy
+4,130
New +$541K 0.04% 116

Other funds holding ZBH

River Global Investors's ZBH Position: Q4 2024 in Review

River Global Investors reduced its Zimmer Biomet (ZBH) stake by 40% in Q4 2024, selling an estimated $899K and leaving 12,706 shares worth $1.34M. The position accounts for 0.26% of the portfolio, ranked #65.

River Global Investors first reported a position in ZBH in Q1 2020 and has held it in 15 quarters since. The position peaked at $2.41M in Q2 2023. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • River Global Investors held 12,706 shares of Zimmer Biomet worth $1.34M as of Q4 2024.
  • River Global Investors sold 8,378 Zimmer Biomet shares in Q4 2024, an estimated $899K.
  • Zimmer Biomet made up 0.26% of River Global Investors's portfolio in Q4 2024, its #65 holding.
  • River Global Investors first reported a position in Zimmer Biomet in Q1 2020 and has held it in 15 quarters since.
  • River Global Investors's Zimmer Biomet position peaked at $2.41M in Q2 2023.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on River Global Investors's 13F filing for Q4 2024, filed 7 Feb 2025.